Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis

AMPH

Market Closed

Amphastar Pharmaceuticals, Inc.

NASDAQHealthcare Drug Manufacturers - Specialty & Generic

2.03K employees

CEO: Yongfeng Zhang

Founded: 2014

$20.53

+$0.00(+NaN%)

Market Cap

905.23M

Beta

0.90

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

AMPH Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for AMPH built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Buy

Pass %

71.43%

Score

5/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$88.31

AI Price Target

Machine learning • Price prediction

$21.27

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$7.37

Financial Health

Bankruptcy risk assessment

2.22

Quality Score

Financial strength rating

6.00

AI Investment Grade

Deep analysis of filings & news

72.00

Key Investment Highlights

Important factors affecting AMPH investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

74.36% Good

Conditions Met

29.00/39.00

Due Diligence Score

74.36%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Pass
	Fail
	Pass
	Fail
	Pass

Showing 1 to 6 of 46 conditions